Literature DB >> 3959356

Paradoxical elevations of plasma glucagon levels in patients after pancreatectomy or gastrectomy.

K Ohtsuka, Y Nimura, K Yasui.   

Abstract

In twenty-five patients undergoing total pancreatectomy (TP), twenty distal gastrectomy (DG) and twenty healthy subjects, effects of oral glucose loading on the plasma glucagon (IRG) levels were determined. Plasma IRG levels were elevated after glucose loading in the TP and DG patients, but not in the healthy subjects. To clarify events related to the elevations in IRG, the plasma IRG components were analyzed by gel filtration in 6 of the TP patients, 5 of the DG patients and 4 of the controls. In the TP group, IRG3500 was not detectable either in the basal state or after glucose loading, while IRG9000 was markedly increased after glucose (p less than 0.002). In the DG group, IRG3500 was significantly suppressed after glucose (p less than 0.05), but IRG9000 was clearly increased (p less than 0.005). In the controls, IRG3500 was suppressed after glucose (p less than 0.05), however, IRG9000 was not detected throughout the examination. Thus, in patients with TP or DG, the essential cause of the high responses of plasma glucagon after oral glucose loading was the increase in IRG9000. Because the food passage route is much the same in TP and DG patients, the IRG9000 elevations are probably related to secretion in the digestive tract.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959356     DOI: 10.1007/bf02471062

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  18 in total

1.  Glucagon antibodies and an immunoassay for glucagon.

Authors:  R H UNGER; A M EISENTRAUT; M S McCALL; L L MADISON
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

2.  Heterogeneity of plasma glucagon in man.

Authors:  J B Jaspan; S F Kuku; J D Locker; A Huen; D S Emmanouel; A I Katz; A H Rubenstein
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

3.  Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.

Authors:  J L Botha; A I Vinik; P T Child; M Paul; W P Jackson
Journal:  Horm Metab Res       Date:  1977-05       Impact factor: 2.936

4.  Presence of glucagon immunoreactivity in the globulin fraction of human plasma ("big plasma glucagon").

Authors:  I Valverde; M L Villanueva; I Lozano; J Marco
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

5.  Plasma glucose, insulin, pancreatic, and enteroglucagon levels in normal and depancreatized dogs.

Authors:  T Matsuyama; P P Foà
Journal:  Proc Soc Exp Biol Med       Date:  1974-10

6.  Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs.

Authors:  M Vranic; S Pek; R Kawamori
Journal:  Diabetes       Date:  1974-11       Impact factor: 9.461

7.  [Heterogeneity of plasma glucagon in patients with total pancreatectomy and gastrectomy].

Authors:  K Ohtsuka; H Takaesu; Y Nimura; K Nagai; T Hayakawa
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1984-09

8.  Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.

Authors:  K Mashiter; P E Harding; M Chou; G D Mashiter; J Stout; D Diamond; J B Field
Journal:  Endocrinology       Date:  1975-03       Impact factor: 4.736

9.  Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.

Authors:  W A Muller; M Berger; P Suter; H J Cüppers; J Reiter; T Wyss; P Berchtold; F H Schmidt; J P Assal; A E Renold
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

10.  Effects of total pancreatectomy on the secretion of gut glucagon in humans.

Authors:  K Yasui
Journal:  Jpn J Surg       Date:  1983-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.